MovDisordV3, Main, Merge, bibRecord, 008A47

Letter to the editor

Identifieur interne : 008A47 ( Main/Merge ); précédent : 008A46; suivant : 008A48

Letter to the editor

Auteurs : Peter Vieregge [Allemagne] ; Ilse Heberlein [Allemagne]

Source :

Movement Disorders [ 0885-3185 ] ; 1995-05.

RBID : ISTEX:4B753DB240AD26867D480CB9EE074167E27FAD28

English descriptors

KwdEn :
- Aged, Animals, Brain (physiopathology), Carrier Proteins (physiology), Dopamine Plasma Membrane Transport Proteins, Humans, Liver (physiopathology), Membrane Glycoproteins, Membrane Transport Proteins, Nerve Tissue Proteins, Nicotine (administration & dosage), Nicotine (pharmacokinetics), Parkinson Disease (physiopathology), Smoking (adverse effects), Smoking (physiopathology), Smoking Cessation.
MESH :
- chemical , administration & dosage : Nicotine.
- chemical , pharmacokinetics : Nicotine.
- chemical , physiology : Carrier Proteins.
- adverse effects : Smoking.
- physiopathology : Brain, Liver, Parkinson Disease, Smoking.
- Aged, Animals, Dopamine Plasma Membrane Transport Proteins, Humans, Membrane Glycoproteins, Membrane Transport Proteins, Nerve Tissue Proteins, Smoking Cessation.

Url:

https://api.istex.fr/document/4B753DB240AD26867D480CB9EE074167E27FAD28/fulltext/pdf

DOI: 10.1002/mds.870100327

Links to Exploration step

ISTEX:4B753DB240AD26867D480CB9EE074167E27FAD28

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Letter to the editor</title>
<author><name sortKey="Vieregge, Peter" sort="Vieregge, Peter" uniqKey="Vieregge P" first="Peter" last="Vieregge">Peter Vieregge</name>
</author>
<author><name sortKey="Heberlein, Ilse" sort="Heberlein, Ilse" uniqKey="Heberlein I" first="Ilse" last="Heberlein">Ilse Heberlein</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:4B753DB240AD26867D480CB9EE074167E27FAD28</idno>
<date when="1995" year="1995">1995</date>
<idno type="doi">10.1002/mds.870100327</idno>
<idno type="url">https://api.istex.fr/document/4B753DB240AD26867D480CB9EE074167E27FAD28/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003E80</idno>
<idno type="wicri:Area/Istex/Curation">003E80</idno>
<idno type="wicri:Area/Istex/Checkpoint">003D16</idno>
<idno type="wicri:doubleKey">0885-3185:1995:Vieregge P:letter:to:the</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:7651462</idno>
<idno type="wicri:Area/PubMed/Corpus">004971</idno>
<idno type="wicri:Area/PubMed/Curation">004971</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004947</idno>
<idno type="wicri:Area/Ncbi/Merge">004741</idno>
<idno type="wicri:Area/Ncbi/Curation">004741</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004741</idno>
<idno type="wicri:doubleKey">0885-3185:1995:Vieregge P:nicotine:consumption:and</idno>
<idno type="wicri:Area/Main/Merge">008A47</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Letter to the editor</title>
<author><name sortKey="Vieregge, Peter" sort="Vieregge, Peter" uniqKey="Vieregge P" first="Peter" last="Vieregge">Peter Vieregge</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Medical University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Heberlein, Ilse" sort="Heberlein, Ilse" uniqKey="Heberlein I" first="Ilse" last="Heberlein">Ilse Heberlein</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Medical University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1995-05">1995-05</date>
<biblScope unit="vol">10</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="359">359</biblScope>
<biblScope unit="page" to="360">360</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">4B753DB240AD26867D480CB9EE074167E27FAD28</idno>
<idno type="DOI">10.1002/mds.870100327</idno>
<idno type="ArticleID">MDS870100327</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Animals</term>
<term>Brain (physiopathology)</term>
<term>Carrier Proteins (physiology)</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Humans</term>
<term>Liver (physiopathology)</term>
<term>Membrane Glycoproteins</term>
<term>Membrane Transport Proteins</term>
<term>Nerve Tissue Proteins</term>
<term>Nicotine (administration & dosage)</term>
<term>Nicotine (pharmacokinetics)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Smoking (adverse effects)</term>
<term>Smoking (physiopathology)</term>
<term>Smoking Cessation</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Nicotine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Nicotine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>Carrier Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Smoking</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Brain</term>
<term>Liver</term>
<term>Parkinson Disease</term>
<term>Smoking</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Animals</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Humans</term>
<term>Membrane Glycoproteins</term>
<term>Membrane Transport Proteins</term>
<term>Nerve Tissue Proteins</term>
<term>Smoking Cessation</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<double doi="10.1002/mds.870100327"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Letter to the editor</title>
<author><name sortKey="Vieregge, Peter" sort="Vieregge, Peter" uniqKey="Vieregge P" first="Peter" last="Vieregge">Peter Vieregge</name>
</author>
<author><name sortKey="Heberlein, Ilse" sort="Heberlein, Ilse" uniqKey="Heberlein I" first="Ilse" last="Heberlein">Ilse Heberlein</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:4B753DB240AD26867D480CB9EE074167E27FAD28</idno>
<date when="1995" year="1995">1995</date>
<idno type="doi">10.1002/mds.870100327</idno>
<idno type="url">https://api.istex.fr/document/4B753DB240AD26867D480CB9EE074167E27FAD28/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003E80</idno>
<idno type="wicri:Area/Istex/Curation">003E80</idno>
<idno type="wicri:Area/Istex/Checkpoint">003D16</idno>
<idno type="wicri:doubleKey">0885-3185:1995:Vieregge P:letter:to:the</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Letter to the editor</title>
<author><name sortKey="Vieregge, Peter" sort="Vieregge, Peter" uniqKey="Vieregge P" first="Peter" last="Vieregge">Peter Vieregge</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Medical University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Heberlein, Ilse" sort="Heberlein, Ilse" uniqKey="Heberlein I" first="Ilse" last="Heberlein">Ilse Heberlein</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Medical University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1995-05">1995-05</date>
<biblScope unit="vol">10</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="359">359</biblScope>
<biblScope unit="page" to="360">360</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">4B753DB240AD26867D480CB9EE074167E27FAD28</idno>
<idno type="DOI">10.1002/mds.870100327</idno>
<idno type="ArticleID">MDS870100327</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
</ISTEX>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Nicotine consumption and Parkinson's disease--does the smoke clear up?</title>
<author><name sortKey="Vieregge, P" sort="Vieregge, P" uniqKey="Vieregge P" first="P" last="Vieregge">P. Vieregge</name>
</author>
<author><name sortKey="Heberlein, I" sort="Heberlein, I" uniqKey="Heberlein I" first="I" last="Heberlein">I. Heberlein</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1995">1995</date>
<idno type="RBID">pubmed:7651462</idno>
<idno type="pmid">7651462</idno>
<idno type="doi">10.1002/mds.870100327</idno>
<idno type="wicri:Area/PubMed/Corpus">004971</idno>
<idno type="wicri:Area/PubMed/Curation">004971</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004947</idno>
<idno type="wicri:Area/Ncbi/Merge">004741</idno>
<idno type="wicri:Area/Ncbi/Curation">004741</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004741</idno>
<idno type="wicri:doubleKey">0885-3185:1995:Vieregge P:nicotine:consumption:and</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Nicotine consumption and Parkinson's disease--does the smoke clear up?</title>
<author><name sortKey="Vieregge, P" sort="Vieregge, P" uniqKey="Vieregge P" first="P" last="Vieregge">P. Vieregge</name>
</author>
<author><name sortKey="Heberlein, I" sort="Heberlein, I" uniqKey="Heberlein I" first="I" last="Heberlein">I. Heberlein</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1995" type="published">1995</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Animals</term>
<term>Brain (physiopathology)</term>
<term>Carrier Proteins (physiology)</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Humans</term>
<term>Liver (physiopathology)</term>
<term>Membrane Glycoproteins</term>
<term>Membrane Transport Proteins</term>
<term>Nerve Tissue Proteins</term>
<term>Nicotine (administration & dosage)</term>
<term>Nicotine (pharmacokinetics)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Smoking (adverse effects)</term>
<term>Smoking (physiopathology)</term>
<term>Smoking Cessation</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Nicotine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Nicotine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>Carrier Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Smoking</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Brain</term>
<term>Liver</term>
<term>Parkinson Disease</term>
<term>Smoking</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Animals</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Humans</term>
<term>Membrane Glycoproteins</term>
<term>Membrane Transport Proteins</term>
<term>Nerve Tissue Proteins</term>
<term>Smoking Cessation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
</PubMed>
</double>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008A47 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 008A47 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     ISTEX:4B753DB240AD26867D480CB9EE074167E27FAD28
   |texte=   Letter to the editor
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Letter to the editor

Letter to the editor

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.